10-K: CareCloud Reports Profitable Year-End Results Amid Strategic Shifts
Annual Results
CareCloud reports a profitable year for 2024, driven by cost reductions and strategic focus, despite a slight revenue decrease.
Summary
- CareCloud, Inc. reported a profitable year for the fiscal year ended December 31, 2024.
- The company provides technology-enabled services and generative AI solutions for healthcare revenue cycle management.
- Net revenue for 2024 was $110.8 million, a decrease of 5% compared to $117.1 million in 2023.
- The company achieved a GAAP net income of $7.9 million, a significant improvement from a net loss of $48.7 million in the previous year.
- Adjusted EBITDA increased to $24.1 million in 2024 from $15.4 million in 2023.
- The company is focused on reducing costs, maintaining profitability, and generating positive free cash flow.
- A majority of the Series A Preferred Stock was converted into common stock in March 2025.
- The company resumed paying monthly dividends on its preferred stock in February 2025 after a suspension in December 2023.
Sentiment
Score: 7
Explanation: The document presents a mixed picture, with improved profitability offset by a slight revenue decline. The company's strategic focus and cost-cutting measures are positive, but risks related to competition and regulation remain.
Positives
- The company achieved a significant improvement in net income, turning a substantial loss into a profit.
- Adjusted EBITDA increased, indicating improved operational efficiency.
- The company maintained a high customer renewal rate, demonstrating customer satisfaction and retention.
- The company successfully reduced its debt by repaying its line of credit.
- The company is focused on reducing costs, maintaining profitability, and generating positive free cash flow.
Negatives
- Net revenue decreased by 5% compared to the previous year.
- The company incurred restructuring costs related to workforce realignment.
- The company suspended dividend payments on preferred stock in December 2023, although payments resumed in February 2025.
Risks
- The company operates in a highly competitive industry.
- The company's success depends on its offshore operations, which are subject to political and economic risks.
- The healthcare industry is heavily regulated, and failure to comply with regulations could result in liabilities.
- The company may be subject to liability for the content it provides to customers and their patients.
- The company's financial results may fluctuate in future periods, and it may fail to meet investor expectations.
Future Outlook
The company expects to have increased software capabilities and offer additional complementary business services that will address the needs of the ever-changing, dynamic market conditions of the U.S. healthcare space.
Management Comments
- The Company is focused on reducing costs, maintaining profitability and generating positive free cash flow in order to continue paying the Preferred Stock dividends, including those that are in arrears.
- The Company is focused on always reassessing the market landscape, seeking new opportunities to meet the needs of the clients in our addressable market with our products and services.
Industry Context
The healthcare IT market is experiencing significant growth, driven by the modernization of the healthcare industry and the increased adoption of value-based care models. CareCloud is positioned to capitalize on these trends with its comprehensive suite of technology-enabled solutions.
Comparison to Industry Standards
- The U.S. Healthcare IT industry market is projected to reach $325.2 billion by 2033, growing at a 13.1% compound annual growth rate (CAGR).
- The U.S. EHR market was estimated to be valued at $11.4 billion in 2023 and expected to grow at a CAGR of 2.24% from 2024 to 2030.
- The Telehealth market is estimated to be approximately $42.54 billion in 2024 with a CAGR of 23.8% from 2025 to 2030.
- CareCloud competes with larger healthcare IT companies, such as athenahealth, Inc., eClinicalWorks, Greenway Medical Technologies, Inc., NextGen, R1 RCM and Veradigm.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Co-Chief Executive Officer | Larry Steenvoorden | Stephen Snyder | 2025-01-01 | Not specified |
| Co-Chief Executive Officer | Larry Steenvoorden | A. Hadi Chaudhry | 2025-01-01 | Not specified |
Related Party Transactions
- The Company had sales to a related party, a physician who is the wife of the Executive Chairman.
- The Company leases its corporate offices in New Jersey, its temporary housing for its foreign visitors, a storage facility, its backup operations center in Bagh, Pakistan and an apartment for temporary housing in Dubai, the UAE, from the Executive Chairman.
- The Company also leases two facilities used for temporary housing from a management employee.
Stakeholder Impact
- Shareholders will benefit from the company's improved profitability and resumption of dividend payments.
- Employees may be affected by the company's restructuring efforts and workforce realignment.
- Customers will benefit from the company's continued investment in technology and services.
- The company's success will contribute to the growth of the healthcare IT industry.
Next Steps
- The company will continue to focus on reducing costs, maintaining profitability, and generating positive free cash flow.
- The company will continue to enhance its solutions with new functionality and features.
- The company will continue to expand into new categories/specialties/markets.
- The company will continue to drive organic growth to expand its client base.
- The company will continue to extend its relationships with existing clients.
- The company will continue to leverage significant cost advantages provided by its technology and global workforce.
- The company will continue to develop its partner ecosystem.
Key Dates
| Date | Description |
|---|---|
| 2001-09-28 | CareCloud was incorporated in Delaware. |
| 2014-07-23 | Common stock listed on the Nasdaq Global Market. |
| 2023-12 | Dividends on Preferred Stock were suspended. |
| 2024-12-31 | End of fiscal year 2024. |
| 2025-02 | Monthly dividend payments on Preferred Stock resumed. |
| 2025-03 | Majority of Series A Preferred Stock converted into common stock. |
| 2025-05-27 | Date of the Annual Meeting of Shareholders. |
| 2025-10 | Current credit facility expires. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.